Agios Pharma (NASDAQ: AGIO) reported Q2 EPS of ($1.31), $0.06 better than the analyst estimate of ($1.37). Revenue for the quarter came in at $37.35 million versus the consensus estimate of $37.71 million.

For earnings history and earnings-related data on Agios Pharma (AGIO) click here.